Glioma most commonly contains the IDHR132H point mutation [209]; however, other cancers mainly express other IDH variants, including IDH1R132C and IDH1R132G, but also mutations in IDH2, commonly IDH2R140Q and IDH2R172K [210]. Here, IDH2 is linked to central nervous system cancer.